NextRNA Therapeutics, a biotechnology company developing small molecule therapeutics targeting long non-coding RNAs and RNA-binding proteins is seeking novel small molecules that target RNA, RNA-binding proteins or RNA-modifying proteins for treating diseases in oncology, neuroscience, and inflammation.
In Scope:
- Ideally genetically driven disease mechanisms
- RNA targets can be long non-coding RNAs, non-coding RNAs (e.g. microRNAs), or messenger RNAs. Protein targets can be RNA-binding proteins, RNA-modifying proteins, or DNA-binding proteins (e.g. Transcription...